글로벌 신경 조절 시장 규모, 점유율 및 추세 분석 보고서 – 산업 개요 및 2031년까지의 예측

글로벌 신경 조절 시장 분석

신경 조절 시장은 예측 기간 동안 빠르게 증가할 것으로 추정됩니다. 신경 조절 장치는 의학 분야에서 가장 빠르게 성장하는 분야 중 하나로, 광범위한 전문가가 참여하고 전 세계적으로 다양한 질병을 앓고 있는 수십만 명의 환자에게 영향을 미칩니다. 신경 조절 장치는 만성 통증 환자의 치료에 더욱 중요해졌습니다. 이러한 장치는 통증의 불쾌한 감각적 경험과 통증의 기능적 및 행동적 결과를 완화하도록 설계되었습니다. 따라서 이러한 요소는 시장에서 신경 조절 기술에 대한 수요를 높일 것입니다.

글로벌 신경 조절 시장 규모

글로벌 신경조절 시장 규모는 2023년에 80억 6천만 달러로 평가되었으며, 2031년까지 193억 9천만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 연평균 성장률은 11.60%입니다.

보고 범위 및 시장 세분화       

Neuromodulation Market Definition

Neuromodulation is an intracranial electrical neuromodulation therapy that the FDA has approved for the treatment of most neurological diseases, including bladder control, headache, tremors, chronic pain, stroke, minimally conscious state, and spinal cord injury, which are most common in the elderly population. Many newcomers to the neuromodulation business are looking into using technology to treat obesity, depression, leg pain, treatment-resistant hypertension, sexual dysfunction, urinary tract diseases, heart failure, and drug addiction, among other conditions.

Neuromodulation Market Dynamics

Drivers

• Increasing incidences of neurological diseases

The rising incidences of neurological diseases will cushion the market's growth rate. Along with this, the increase in variety of headache and brain diseases patients will enhance the demand for neuromodulation market.

• Rise in the growth of neurostimulators

The neuromodulation market is being driven by the increase in growth of neurostimulators within the treatment of depression and sleep apnea.

Furthermore, the rising awareness about neurodegenerative diseases will be a major factor influencing the growth of the neuromodulation market. Along with this, increasing urbanization and the rising geriatric population are also the driving factors accelerating the growth of the neuromodulation market. Also, the rise in the changing lifestyle and increasing expenditure on healthcare infrastructure are the major market drivers that will further escalate the growth of neuromodulation market. Another significant factor that will cushion the neuromodulation market's growth rate is the rising gastric, chronic and nerve disability conditions.

Opportunities

• Growing number of R&D activities

Moreover, the rising number of research and development activities will provide beneficial opportunities for the neuromodulation market growth. Along with this, increase in extensive new indications and target applications linked with robust product pipeline offered by various market players will flourish the growth rate of neuromodulation market.  

Moreover, growing focus of manufacturers on the adoption of advanced technologies and increase in the number of emerging markets will further provide beneficial opportunities for the neuromodulation market growth during the forecast period.

Restraints/Challenges 

• High cost associated with neuromodulation devices

However, the high cost associated with neuromodulation devices and procedures will impede the neuromodulation market's growth rate.

On the other hand, the dearth of skilled professionals in under-developed nations will challenge the neuromodulation market. Additionally, emergence of unfavourable conditions due to COVID-19 outbreak and lack of awareness will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.

This neuromodulation market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the neuromodulation market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Neuromodulation Market

The fast spread of coronavirus caused the COVID-19 pandemic outbreak. The transmission of this virus has a significant impact on many parts of the globe. Countries have yet to recover from this infection, and a new form of the virus has emerged as a big issue for them. The global economy is causing issues for businesses and governments alike. Apart from the healthcare industry, the pandemic has significantly impacted many sectors. The healthcare sector is experiencing a surge in demand as a result of the pandemic, and the reason is clear. With the rising number of health problems caused by the pandemic, the healthcare sector will grow even more. Neuromodulation devices are used to treat a wide range of illnesses. Many people have encountered serious health difficulties as a result of the virus; as a result, demand for neuromodulation devices will increase. However, the enforcement of lockdown is expected to cause problems in the manufacturing industry for neuromodulation devices.

Neuromodulation Market Scope

The neuromodulation market is segmented on the basis of technology, application, biomaterial, and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Technology

• Internal Neuromodulation
• External Neuromodulation

On the basis of technology, the neuromodulation market is segmented into internal neuromodulation and external neuromodulation.

Application

• Spinal Cord Stimulation
• Deep Brain Stimulation
• Sacral Nerve Stimulation
• Vagus Nerve Stimulation
• Gastric Electrical Stimulation
• Transcutaneous Electrical Nerve Stimulation
• Repetitive Transcranial Magnetic Stimulation
• Respiratory Electrical Stimulation

On the basis of application, the neuromodulation market is segmented into spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, gastric electrical stimulation, transcutaneous electrical nerve stimulation, repetitive transcranial magnetic stimulation, and respiratory electrical stimulation.

Biomaterial

• Ceramics Biomaterials
• Metallic Biomaterials
• Polymeric Biomaterials

On the basis of biomaterials, the neuromodulation market is segmented into ceramics biomaterials, metallic biomaterials, and polymeric biomaterials.

End-User

• Hospitals
• Clinics
• Home Healthcare

On the basis of end-user, the neuromodulation market is segmented into hospitals, clinics, and home healthcare.

Neuromodulation Market Regional Analysis

The neuromodulation market is analysed and market size insights and trends are provided by country, technology, application, biomaterial, and end-user as referenced above.

The countries covered in the neuromodulation market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the neuromodulation market because of the presence of major key players in this region. Additionally, the growing acceptance of advanced technologies will flourish the market's growth rate in this region. 

Asia-Pacific is expected to grow during the forecast period due to the rising occurrence of established players in this region. Along with this, increasing awareness about mental health and surging prevalence of neurological diseases will flourish the market's growth rate in this region.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 다운스트림 및 업스트림 가치 사슬 분석, 기술 트렌드 및 포터의 5가지 힘 분석, 사례 연구와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 몇 가지 포인터입니다. 또한 글로벌 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향은 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.   

신경 조절 시장 점유율

신경조절 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 프로그램 우위가 있습니다. 위에 제공된 데이터 포인트는 신경조절 시장과 관련된 회사의 초점에만 관련이 있습니다.

시장에서 운영되는 신경 조절 시장 리더는 다음과 같습니다.

• 메드트로닉(아일랜드)
• 보스턴 사이언티픽 코퍼레이션(미국)
• 네브로 주식회사(미국)
• 사이버로닉스 주식회사(미국)
• Inspire Medical Systems, Inc. (미국)
• SPR Therapeutics (미국)
• ALEVA NEUROTHERAPEUTICS SA(스위스)
• 바이오네스 주식회사 (미국)
• ReShape Lifesciences, Inc. (미국)
• 리바노바 PLC(영국)
• 뉴로페이스 주식회사(미국)
• 시냅스 바이오메디컬 주식회사(미국)
• Soterix Medical Inc. (미국)
• Accellent Technologies, Inc. (미국)
• 애벗(미국)
• 바이오벤투스(미국)
• Soterix Medical Inc. (미국)
• Integer Holdings Corporation (미국)
• 네브로 주식회사(미국)
• NeuroSigma, Inc. (미국)
• 뉴로페이스 주식회사(미국)
• 신경학(미국)
• BioControl Medical(이스라엘)

신경 조절 시장의 최신 동향

• 2021년 3월, Helius Medical의 휴대용 신경조절 자극기가 다발성 경화증으로 인한 보행 장애의 단기 치료를 위해 미국 식품의약국으로부터 승인을 받았습니다.

SKU-14265